gravis
The 20 most recent episodes and tracks on this topic, about 11 hours of it.
Saves to your Listen and Watch queue, to pick up on another day or another device.
Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.
- Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Audio19:20Notes
- Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Video19:20Notes
- One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Audio26:33Notes
- One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Video26:33Notes
- Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Audio20:17Notes
- Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Audio29:54Notes
- Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Video20:17Notes
- Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Video29:54Notes
- Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:15:47Notes
- Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Video1:15:47Notes
- Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Audio36:53Notes
- Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Video36:53Notes
- Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Audio27:58Notes
- Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Video27:58Notes
- Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:10:40Notes
- Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Video1:10:40Notes
- Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?PeerVoice Brain & Behaviour Audio16:18Notes
- Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?PeerVoice Brain & Behaviour Video17:00Notes
- Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Brain & Behaviour Audio17:26Notes
- Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Brain & Behaviour Video17:26Notes
This playlist:.m3u.plsAll the feeds behind it
